Related Experiment Video
Updated: Sep 6, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Investigating Diabetes Mellitus Patients' Experiences with Self Monitoring Blood Glucose Methods
Aggeliki Dragamestianou1, Ifigeneia Vasiliki Kontoteza1, Olga Siskou1,2
1Center for Health Services Management and Evaluation, Nursing Department, National and Kapodistrian University of Athens, Athens Greece.
Studies in Health Technology and Informatics
|July 1, 2022
Summary
Patients using flash glucose monitoring (FGM) reported better experiences with diabetes management than self-monitoring blood glucose (SMBG). FGM and SMBG offer different benefits for glucose monitoring in diabetes mellitus.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Patient Experience Research
Background:
- Diabetes mellitus (DM) is a prevalent metabolic disorder characterized by hyperglycemia.
- Effective glucose monitoring is crucial for managing diabetes mellitus (DM).
- Self-monitoring blood glucose (SMBG) and flash glucose monitoring (FGM) are key methods for individual diabetes management.
Purpose of the Study:
- To investigate and compare patient experiences with different self-monitoring blood glucose methods.
- To assess the convenience, effectiveness, and discreetness of SMBG versus FGM.
Main Methods:
- A cross-sectional study utilizing the Glucose Monitoring Experiences Questionnaire (GME-Q).
- Inclusion of adult patients with diabetes mellitus type 1 (DM 1) or type 2 (DM 2).
- Analysis of 253 participants' self-reported experiences with SMBG and FGM.
Main Results:
- Flash glucose monitoring (FGM) users reported higher convenience and effectiveness compared to self-monitoring blood glucose (SMBG) users.
- SMBG was perceived as more discreet than FGM.
- No significant associations were found between gender or age and the effectiveness, discreetness, or convenience of glucose monitoring methods.
- Patients with diabetes type 2 reported higher convenience and discreetness scores than those with diabetes type 1.
Conclusions:
- Enhanced self-glucose monitoring experiences are vital for effective management of both DM 1 and DM 2.
- Further research is recommended on glucose monitoring experiences, considering cost, user training, and impact on insulin/diet calculations.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:15Diabetes: Management and Pharmacotherapy
353
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
353
01:15Diabetes: Symptoms, Diagnosis, and Complications
681
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
681
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:25Errors occurring during blood pressure monitoring
961
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
961
01:15Hypoglycemia and Glucagon
332
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
332